Consolidated Balance Sheets - USD ($)	Jun. 30, 2017	Dec. 31, 2016
Successor [Member]
ASSETS
Cash	$ 144,482
Prepaid expense	21,000
Due from related parties	78,380
Assets held for discontinued operations	258,263
Total Current Assets	502,125
Assets held for discontinued operations	9,954,981
Total Assets	10,457,106
Current Liabilities
Accounts payable and accrued liabilities	826,952
Due to related parties	0
Convertible notes, net of discount of $283,886	18,514
Liabilities held for discontinued operations	359,797
Total Current Liabilities	1,205,263
Liabilities held for discontinued operations	2,756,380
Total Liabilities	3,961,643
SHAREHOLDERS' EQUITY
Preferred Stock, 9,980,000 shares authorized, $0.001 par value; no shares issued and outstanding	0
Common stock, 500,000,000 shares authorized, par value $0.01; 20,243,429 shares outstanding (December 31, 2016 - 9,681,929 shares outstanding)	202,434
Additional paid-in capital	8,451,422
Accumulated deficit	(2,158,393)
Total Corix Bioscience, Inc.'s Shareholders' Equity	6,495,463
Non-controlling interest	0
Total Shareholders' Equity	6,495,463
Total Liabilities and Shareholders' Equity	10,457,106
Predecessor [Member]
ASSETS
Cash		$ 2,151
Prepaid expense		24,125
Due from related parties		0
Assets held for discontinued operations		211,558
Total Current Assets		237,834
Assets held for discontinued operations		11,131,838
Total Assets		11,369,672
Current Liabilities
Accounts payable and accrued liabilities		65,788
Due to related parties		407,728
Convertible notes, net of discount of $283,886		0
Liabilities held for discontinued operations		600,466
Total Current Liabilities		1,073,982
Liabilities held for discontinued operations		4,690,077
Total Liabilities		5,764,059
SHAREHOLDERS' EQUITY
Preferred Stock, 9,980,000 shares authorized, $0.001 par value; no shares issued and outstanding		0
Common stock, 500,000,000 shares authorized, par value $0.01; 20,243,429 shares outstanding (December 31, 2016 - 9,681,929 shares outstanding)		96,819
Additional paid-in capital		16,803,120
Accumulated deficit		(12,424,339)
Total Corix Bioscience, Inc.'s Shareholders' Equity		4,475,600
Non-controlling interest		1,130,013
Total Shareholders' Equity		5,605,613
Total Liabilities and Shareholders' Equity		11,369,672
Preferred Class A [Member] | Successor [Member]
SHAREHOLDERS' EQUITY
Preferred Stock - Series A, 20,000 shares authorized, $0.001 par value; no shares issued and outstanding	$ 0
Preferred Class A [Member] | Predecessor [Member]
SHAREHOLDERS' EQUITY
Preferred Stock - Series A, 20,000 shares authorized, $0.001 par value; no shares issued and outstanding		$ 0